(UroToday.com) The 2021 American Society of Clinical Oncology (ASCO) meeting included a session discussing the application of genomic testing treatments for patients with prostate cancer, including a presentation by Dr. Edward Schaeffer discussing the urology perspective of applying precision health to high-risk, localized disease.